Bacillus altitudinis F7 and application thereof
By screening and applying Bacillus uprising F7, the problem of poor glycolipid metabolism in high-starch feed in juvenile largemouth black bass was solved, which improved carbohydrate utilization and growth performance, reduced feed costs, and improved liver health.
Patent Information
- Application Number
- CN202411199901.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-29
- Publication Date
- 2024-11-19
AI Technical Summary
After consuming high-starch feed, juvenile fish with large mouth black bass are prone to poor glycolipid metabolism, resulting in poor body shape and liver lesions, and the problem of excessive carbohydrate content in existing feeds.
By screening and applying Bacillus algae F7, this strain was deposited in the China Microbial Sprout Preservation Management Committee for the preparation of bacterial agents or feed additives to improve the adverse effects of high-wheat starch feed on the glycolipid metabolism of largemouth black bass juvenile fish.
Bacillus highland F7 can effectively improve the utilization rate of carbohydrates by largemouth black bass, reduce feed costs, improve glycolipid metabolism, alleviate the inhibition of high starch on the growth of young fish, and improve liver health.
Smart Images

Figure CN118978994A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the field of biotechnology, in particular to a strain of Bacillus subtilis F7 and application thereof. Background Art
[0002] Largemouth bass (Micropterus salmoides, Lacepède 1802) belongs to the Perciformes, Porcoidei, Cehtrachidae, Micropterus in taxonomy. It is divided into northern subspecies and Florida subspecies, also known as largemouth bass. Largemouth bass is a famous freshwater specialty species in domestic aquaculture. It is a typical carnivorous fish, and its utilization rate of carbohydrates is lower than that of herbivorous fish and omnivorous fish. The liver is the main organ for fish sugar metabolism. The carbohydrates in the feed will inevitably affect the biochemical composition and histology of its liver tissue after digestion, absorption and metabolism by fish. Largemouth bass tend to gain weight after eating compound feed, have a bad body shape, and are prone to liver lesions, resulting in the so-called "fatty liver". This is to a certain extent because the compound feed is nutritionally unbalanced and the carbohydrate content in the feed exceeds the tolerance of largemouth bass. Largemouth bass is a typical carnivorous animal with low tolerance to starchy carbohydrates. Therefore, it is crucial to develop a formulation that can improve the adverse effects of high-starch diets on the glucose and lipid metabolism of largemouth bass juveniles. Summary of the invention
[0003] The present invention screened out a strain of Bacillus altitudinis F7 in the intestine of largemouth bass by comparing the intestinal microorganisms of largemouth bass fed with 6%, 12% and 18% starch feed for 70 days, and further proved through animal experiments that Bacillus altitudinis F7 can effectively improve the adverse effects of high-wheat starch diet on the glucose and lipid metabolism of largemouth bass juveniles.
[0004] In order to achieve the above-mentioned purpose of the present invention, the following technical solutions are adopted:
[0005] A strain of Bacillus subtilis F7, the faecal enterococcus is deposited in the General Microbiology Center of China Microorganism Culture Collection Committee (abbreviated as: CGMCC, No. 3, No. 1 Beichen West Road, Chaoyang District, Beijing), and its deposit number is CGMCC No.28886.
[0006] Culture of the above-mentioned Bacillus sp.
[0007] The use of the above-mentioned Bacillus subtilis or the culture of Bacillus subtilis in the preparation of bacterial agents or feed additives.
[0008] A bacterial agent comprising the above-mentioned Bacillus subtilis or a culture thereof.
[0009] A feed additive comprising the above-mentioned Bacillus subtilis or a culture thereof.
[0010] The term "culture" refers to a liquid or solid product (all substances in the culture container, fermentation products) that has a microbial community after artificial inoculation and culture. That is, the product obtained by growing and / or amplifying microorganisms, which can be a biologically pure culture of microorganisms, or it can contain a certain amount of culture medium, metabolites or other components produced during the culture process.
[0011] Compared with the prior art, the invention has the following beneficial effects: a large number of genes involved in sugar and lipid metabolism exist in the genome of the Bacillus sp. F7 of the invention, which has a biological basis for regulating sugar and lipid metabolism of the host. The invention can improve the adverse effects of high wheat starch diet on sugar and lipid metabolism of juvenile largemouth bass, improve the utilization rate of carbohydrates by largemouth bass, and reduce feed costs.
[0012] Collection Instructions
[0013] Deposit address: Institute of Microbiology, Chinese Academy of Sciences, No. 3, Yard 1, Beichen West Road, Chaoyang District, Beijing
[0014] Date of deposit: November 6, 2023
[0015] Bacteria name: Bacillus subtilis
[0016] Latin name: Bacillus altitudinis
[0017] Strain ID: F7
[0018] Depository: China National Microbiological Culture Collection Administration General Microbiology Center
[0019] Abbreviation of depository institution: CGMCC
[0020] CGMCC Registration Number: CGMCC No.28886 BRIEF DESCRIPTION OF THE DRAWINGS
[0021] Figure 1 This is the species distribution map of the sequences aligned to the Nr database.
[0022] Figure 2 Classification statistics of GO functional annotations.
[0023] Figure 3 KEGG annotation classification statistics.
[0024] Figure 4This is the result of the KEGG glycolysis / gluconeogenesis metabolic pathway. The numbers in the boxes represent the EC numbers of the key enzymes in the metabolic pathway, and the blue boxes indicate the presence of coding genes corresponding to the relevant enzymes in the genome.
[0025] Figure 5 This is the result of the KEGG fatty acid biosynthesis metabolic pathway. The numbers in the boxes represent the EC numbers of the key enzymes in the metabolic pathway, and the blue boxes indicate the presence of coding genes corresponding to the relevant enzymes in the genome.
[0026] Figure 6 The distribution ratio of carbohydrate enzymes
[0027] Figure 7 Circle map of the genome. DETAILED DESCRIPTION
[0028] In order to better understand the present invention, the present invention is further described in detail below in conjunction with the embodiments. However, those skilled in the art understand that the following embodiments are not limitations on the scope of protection of the present invention, and any changes and modifications made on the basis of the present invention are within the scope of protection of the present invention.
[0029] Unless otherwise specified, the experimental methods used in the following examples are conventional methods.
[0030] Unless otherwise specified, the materials and reagents used in the following examples can be obtained from commercial sources.
[0031] Example 1
[0032] Strain source
[0033] By comparing the intestinal microorganisms of largemouth bass fed with 6%, 12% and 18% starch diets for 70 days, it was found that the content of Bacillus subtilis F7 (colony morphology: medium to small, dry, round, with white spots in the middle) in the intestine of largemouth bass in the 6% starch group was: 2.66×10 5 CFU / g, which was not found in the 12% starch group, but was 1.31×10 4 The content of CFU / g was the highest in the 6% starch group, suggesting that it may be beneficial to improve the adverse effects of high wheat starch diet on the glucose and lipid metabolism of juvenile largemouth bass.
[0034] Strain identification
[0035] A single colony on the plate was selected for 16S rDNA sequencing and the obtained sequence was compared with the known sequence in the GenBank database. It was found that the 16S sequence had a 99.86% identity with the known Bacillus subtilis sequence in the database.
[0036] 16S rDNA sequence of Bacillus subtilis F7 (as shown in SEQ ID NO: 1):
[0037] ATACATGCAAGTCGAGCGGACAGAAGGGAGCTTGCTCCCGGATGTTAGCGGCGGACGGGTGAGTAACACGTGGGTAACCTGCCTGTAAGACTGGGATAACTCCGGGAAACCGGAGCTAATACCGGATAGTTCCTTGAACCGCATGGTTCAAGGATGAAAGACGGTTTCGGCTGTCACTTACAGATGGACCCGCGGCGCATTAGCTAGTTGGTGAGGTAACGGCTCACCAAGGCGACGATGCGTAGCCGACCTGAGAGGGTGATCGGCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCGCAATGGACGAAAGTCTGACGGAGCAACGCCGCGTGAGTGATGAAGGTTTTCGGATCGTAAAGCTCTGTTGTTAGGGAAGAACAAGTGCAAGAGTAACTGCTTGCACCTTGACGGTACCTAACCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGTGGCAAGCGTTGTCCGGAATTATTGGGCGTAAAGGGCTCGCAGGCGGTTTCTTAAGTCTGATGTGAAAGCCCCCGGCTCAACCGGGGAGGGTCATTGGAAACTGGGAAACTTGAGTGCAGAAGAGGAGAGTGGAATTCCACGTGTAGCGGTGAAATGCGTAGAGATGTGGAGGAACACCAGTGGCGAAGGCGACTCTCTGGTCTGTAACTGACGCTGAGGAGCGAAAGCGTGGGGAGCGAACAGGATTAGATACCCTGGTAGTCCACGCCGTAAACGATGAGTGCTAAGTGTTAGGGGGTTTCCGCCCCTTAGTGCTGCAGCTAACGCATTAAGCACTCCGCCTGGGGAGTACGGTCGCAAGACTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCAACG CGAAGAACCTTACCAGGTCTTGACATCCTCTGACAACCCTAGAGATAGGGCTTTCCCTTCGGGGACAGAGTGACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCAACGAGCGCAACCCTTGATCTTAGTTGCCAGCATTC AGTTGGGCACTCTAAGGTGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGACAGAACAAAGGGCTGCGAGACCGCAAGGTTTAGCCAATCCCACAAATCTGTTCTCAGTT CGGATCGCAGTCTGCAACTCGACTGCGTGAAGCTGGAATCGCTAGTAATCGCGGATCAGCATGCCGCGGTGAATACGTTCCCGGGCCTTGTACACACCGCCCGTCACACCACGAGAGTTTGCAACACCCGAAGTCGGTGAGGTAACCTTTATGGAGCCAGCCCGC
[0038] Strain preservation
[0039] The highland Bacillus F7 was deposited in the General Microbiology Center of China Microorganism Culture Collection Administration, and the culture collection number was obtained as CGMCC No.28886.
[0040] Example 2
[0041] Whole genome analysis of strains
[0042] 1. Whole genome sequencing
[0043] Bacillus subtilis F7 was activated and cultured in nutrient broth medium (30°C, 150r / min), and the cells were collected by centrifugation at 8000×g for 2min and transported to Beijing Biomarker Biotechnology Co., Ltd. on dry ice for Pacbio whole genome sequencing. Nucleic acid extraction was completed using the TGuide S96 magnetic bead soil / feces genomic DNA extraction kit, and its integrity was tested by agarose gel electrophoresis. After the nucleic acid sample was qualified, the sequencing library was constructed and placed on the Sequel II (Pacbio, USA) sequencer for sequencing.
[0044] like Figure 1 As shown, the species with the highest similarity to the genome of Bacillus F7 in the Nr database are Bacillus (62.59%) and Bacillus altitudinis (10.51%). After PacBio HIFI mode sequencing, 108138 reads of the genome of Bacillus F7 were obtained, among which reads with a length of more than 2kb were retained after filtering the shorter reads, and the remaining number of reads was 103591. Gene prediction was performed using the software Prodigal v2.6.3, and the number of genes in F7 was predicted to be 3853, the total length of the gene sequence was 3325152bp, and the average length of the predicted gene was 863bp. Using RepeatMasker v4.0.5 software to predict, it was known that the total length of the repeated sequence in F7 was 5948bp, and the content of repeated sequences in the genome was 0.16%. The Infernal v1.1.3 software predicted that the rRNA of F7 is divided into three categories, with a total of 24, including 8 5S rRNAs, 8 23S rRNAs and 8 16S rRNAs. The tRNAscan-SE v2.0 software predicted that the number of tRNAs of F7 is 82, including 31 families, and the total number of non-coding RNAs of F7 is 106. The SignalP v4.0 software predicted that there are 273 signal peptides of F7, and the TMHMM v2.0 software predicted that there are 1065 transmembrane proteins of F7.
[0045] 2. Genome Functional Analysis
[0046] The genome sequence of Bacillus subtilis F7 was obtained by sequencing in PacBio HIFI mode. The number of genes of F7 was predicted by Prodigal v2.6.3, the repeat sequence information was obtained by RepeatMasker v4.0.5, the rRNA information was predicted by Infernal v1.1.3, the tRNA information was predicted by tRNAscan-SE v2.0, the signal peptide information was predicted by SignalP v4.0, and the transmembrane protein information was predicted by TMHMM v2.0. The gene sequence of F7 was compared with the Nr, GO, KEGG and CAZy databases to obtain functional annotation results. The assembled F7 genome circle map was drawn using Circos v0.66, and functional analysis was performed.
[0047] 1.GO functional annotation
[0048] like Figure 2 As shown, the GO database analysis was performed using the software Blast2GO v2.5. The results showed that the total number of GO genes in the genome of Bacillus subtilis F7 was 2915, of which 1332 were involved in metabolic processes, accounting for 45.69%.
[0049] 2.KEGG Annotation
[0050] Depend on Figure 3It can be seen that the total number of genes annotated by KEGG for Bacillus subtilis F7 is 1645, of which 416 are involved in sugar and lipid metabolism (343 genes in the carbohydrate metabolism pathway and 73 genes in the lipid metabolism pathway). The genome of Bacillus sp. F7 contains 46 genes involved in glycolysis / gluconeogenesis of carbohydrate metabolism pathway, 30 genes involved in citrate cycle, 26 genes involved in pentose phosphate pathway, 20 genes involved in pentose and glucuronate interconversions, 25 genes involved in fructose and mannose metabolism, 16 genes involved in galactose metabolism, 18 genes involved in starch and sucrose metabolism, 32 genes involved in amino sugar and nucleotide sugar metabolism, 47 genes involved in pyruvate metabolism, 29 genes involved in glyoxylate and dicarboxylate metabolism, and 31 genes involved in propanoate metabolism. There are 34 genes involved in lipid metabolism, 20 genes involved in butanoate metabolism, 30 genes involved in fatty acid metabolism, 25 genes involved in fatty acid biosynthesis, and 18 genes involved in glycerophospholipid metabolism.
[0051] Depend on Figure 4 It can be seen that the genome of Bacillus subtilis F7 contains genes encoding glycolysis, including glucose kinase (EC: 2.7.1.2), 6-phosphofructokinase 1 (EC: 2.7.1.11) and pyruvate kinase (EC: 2.7.1.40), and genes encoding gluconeogenesis, including fructose-1,6-bisphosphatase I (EC: 3.1.3.11). Figure 5 It can be seen that there are coding genes corresponding to fat synthesis in the genome of Bacillus altaica F7, including acetyl-CoA carboxylase (EC:6.4.1.2).
[0052] 3. Carbohydrate-active enzymes
[0053] The protein sequence of Bacillus subtilis F7 gene was compared with the hidden Markov model of each family in CAZy database (Carbohydrate-active enzymes database) using hmmer software to find carbohydrate-active enzymes in the genome and analyze the conserved carbohydrate-related functional domains of F7. Figure 5 As shown, there are 137 carbohydrate-active enzyme genes in F7, including 42 glycoside hydrolases (GHs) genes, accounting for 30.65%, 38 glycosyltransferases (GTs) genes, accounting for 27.73%, 2 polysaccharide lyases (PLs) genes, accounting for 1.45%, 35 carbohydrate esterases (CEs) genes, accounting for 25.54%, 4 auxiliary activities (AAs) genes, accounting for 2.91% and 16 non-catalytic carbohydrate-binding modules genes, accounting for 11.67%.
[0054] 4. Genome Circle Map
[0055] Figure 6 The Circos map of the assembled genome of Bacillus subtilis F7 was drawn using Circos v0.66. The total number of genes in F7 is 3853, of which 210 genes are involved in carbohydrate transport and metabolism, accounting for 5.45%, and 91 genes are involved in lipid transport and metabolism, accounting for 2.36%.
[0056] In summary, the KEGG annotation results show that the total number of genes involved in sugar and lipid metabolism in the F7 genome is 416, including 343 genes in the carbohydrate metabolism pathway and 73 genes in the lipid metabolism pathway. The F7 genome contains coding genes for sugar and lipid metabolism enzymes, including glucokinase, 6-phosphofructokinase 1 and pyruvate kinase corresponding to glycolysis, fructose-1,6-bisphosphatase I corresponding to gluconeogenesis, and acetyl-CoA carboxylase corresponding to fat synthesis. There are 137 genes encoding carbohydrate-active enzymes in the F7 genome, including 42 genes encoding glycoside hydrolases, 38 genes encoding glycosyltransferases, 2 genes encoding polysaccharide lyases, 35 genes encoding carbohydrate esterases, 4 genes encoding auxiliary oxidoreductases, and 16 genes encoding non-catalytic carbohydrate-binding functional domains. The total number of genes in F7 after assembly is 3853, including 210 genes involved in carbohydrate transport and metabolism, and 91 genes involved in lipid transport and metabolism. It can be seen that there are a large number of genes involved in glycolipid metabolism in the genome of Bacillus subtilis F7, which has a biological basis for regulating the host's glycolipid metabolism.
[0057] Example 3
[0058] Amylase production capacity assay
[0059] Determined by Yoo amylase modified method 1.0×10 8 CFU / mL amylase activity of the supernatant of Bacillus subtilis F7 culture. The results showed that 1.0×10 8 The amylase activity of CFU / mL Bacillus subtilis F7 was 34.65 U / mL (Table 1).
[0060] Table 1 Relative activity of amylase in the culture supernatant of Bacillus subtilis F7
[0061] Strain name Bacillus subtilis F7 Amylase activity (U / mL) 34.65
[0062] Safety analysis of bacteria
[0063] (1) Hemolytic test
[0064] The test bacteria were activated and cultured in nutrient broth (NB) medium (Qingdao Haibo) at 33°C and 180 r / min for 24 h until the concentration reached 1.0×10 8 CFU / mL. Take 20uL of the test bacterial solution and spot it on 3 different positions of the blood agar plate (Qingdao Haibo). After culturing in a 33℃ constant temperature incubator for 24 hours, observe whether there is a hemolytic ring around it to verify whether the test bacterial strain is hemolytic.
[0065] The results showed that after 24 h of culture on the blood agar plate, no transparent zone appeared in Bacillus subtilis F7, indicating that the strain had no hemolytic activity.
[0066] (2) Biosafety evaluation
[0067] The test bacteria were activated and cultured to a concentration of 5.0×10 8 CFU / mL (culture conditions are the same as above), take 200mL of bacterial solution and centrifuge it at 4℃, 5000rpm for 10min, remove the upper culture medium, and dilute the bacterial precipitate with 100mL of physiological saline to a concentration of 1.0×10 8 CFU / mL of bacterial suspension. The test bacterial suspension was injected into normal largemouth bass fry, with 0.5 ml of bacterial solution injected intraperitoneally per 100 grams of fish body weight, and the control group was injected with an equal amount of saline. There were 10 fish in each group, with 3 replicates. The fish were observed for 10 consecutive days, during which they were fed normally, and the sewage was sucked out and the water was changed every day, and the survival rate of each bucket was counted.
[0068] The results showed that there was no mortality in largemouth bass after 10 days of injection with Bacillus subtilis F7, and the swimming and feeding of largemouth bass were normal.
[0069] Example 4
[0070] Strain cultivation and preparation of preparations
[0071] (1) Use an inoculation loop to pick up an appropriate amount of Bacillus subtilis F7 cells preserved on a slant and inoculate them into 6-10 250 mL Erlenmeyer flasks containing 50 mL of culture medium 1 for culture. The composition of culture medium 1 is: 8-12 g of peptone, 2-4 g of beef extract powder, 4-6 g of sodium chloride, 1000 mL of distilled water, and pH value is 7.2±0.2; the culture conditions are: culture temperature 28-32°C; shaker speed 150-180 rpm; culture time 20-24 h; and 300-500 mL of primary seed culture solution is obtained.
[0072] (2) Inoculate the primary seed culture solution into 20-30 2000mL Erlenmeyer flasks containing 400mL of culture medium 2 at a ratio of 2-5%. The composition of culture medium 2 is: 8-12g of peptone, 2-4g of beef extract powder, 4-6g of sodium chloride, 1000mL of distilled water, and pH value is 7.2±0.2; the culture conditions are: culture temperature 28-32°C; shaker speed 150-180rpm; culture time 18-24h; and obtain 8-12L of secondary seed culture solution.
[0073] (3) Preparation of probiotic liquid and feed containing bacteria. According to (2), collect the bacteria by centrifugation (speed of 4000-8000 rpm; centrifugation time of 10 min-20 min), mix with an appropriate amount of physiological saline as a carrier, place in a spray bottle and spray evenly on the 18% starch feed to make a live bacteria content of 1.0×10 8The feed of the experimental group was dried naturally at room temperature for 24 hours, then stored in a ziplock bag and stored in a -20℃ refrigerator.
[0074] The control group was fed with 6% starch (C6 group) and 18% starch (C18 group) (basic feed composition is shown in Table 2), and the experimental group was fed with 18% starch supplemented with 1.0×10 8 CFU / g of Bacillus subtilis F7 (F7 group). The test results are shown in Tables 3 to 5.
[0075] Table 2 Basic feed composition
[0076]
[0077] Experimental results (application effect):
[0078] (1) Effects of Bacillus subtilis F7 on the growth performance of juvenile largemouth bass
[0079] Fish meal, soybean protein concentrate, and casein were used as protein sources, soybean oil and fish oil were used as fat sources, and wheat starch was used as sugar source to prepare isonitrogenous and isolipid test feeds (basic feeds) with starch levels of 6% (low starch) and 18% (high starch), respectively. 8 CFU / g Bacillus subtilis F7, a 42-day breeding experiment was conducted to study the effect of Bacillus subtilis F7 on the growth of largemouth bass. The results in Table 3 showed that compared with the C6 group, the final mean weight (FBW), weight gain rate (WGR), specific growth rate (SGR), and protein efficiency ratio (PER) of largemouth bass in the C18 group were significantly reduced, and the feed conversion rate (FCR) and feed intake (FI) were significantly increased (P < 0.05). Compared with the C18 group, the FBW, WGR, SGR PER of the F7 group were significantly increased, and the FCR was significantly decreased (P < 0.05). The results showed that 18% high starch inhibited the growth of largemouth bass, and Bacillus subtilis F7 could effectively alleviate the inhibition of 18% high starch on the growth of largemouth bass juveniles.
[0080] Table 3 Effects of Bacillus subtilis F7 on the growth performance of juvenile largemouth bass
[0081] Items Group C6 Group C18 F7 Group Initial average weight IBW, g 5.90±0.00 5.90±0.00 5.90±0.00 Final average weight FBW, g 39.54±0.75b 36.72±0.40a 39.80±1.10bc Weight gain rate WGR, % 565.74±12.37b 522.50±6.95a 575.04±18.92bc Specific growth rate SGR, % / d 4.50±0.05b 4.35±0.03a 4.54±0.07bc Protein efficiency PER 1.80±0.03b 1.65±0.04a 1.81±0.03bc Feed Coefficient FCR 1.09±0.04bc 1.20±0.03a 1.09±0.02bc Feed intake FI, g 100g-1BW / d 3.02±0.13b 3.28±0.08a 3.17±0.04ab Survival rate SR, % 100 100 100
[0082] (2) Effects of Bacillus subtilis F7 on liver glycogen content and liver glucose metabolism-related enzyme activities in juvenile largemouth bass
[0083] After the 42-day breeding experiment, the liver glycogen content and glucose metabolism-related enzyme activities of largemouth bass were detected. The results in Table 4 showed that compared with the C6 group, the liver glycogen content of the C18 group increased significantly, the activities of glycolysis-related enzymes (HK, GK, PFK, PK) increased significantly, and the activities of gluconeogenesis-related enzymes (PC and PEPCK) decreased significantly (P < 0.05). Compared with the C18 group, the liver glycogen content of the F7 group decreased significantly, the activities of glycolysis-related enzymes (HK, GK, PK) decreased significantly, and the activity of gluconeogenesis-related enzyme PC increased significantly (P < 0.05). The results showed that 18% high starch led to an increase in liver glycogen in largemouth bass and disordered liver glucose metabolism (promoting glycolysis and inhibiting gluconeogenesis). Highland Bacillus F7 can effectively alleviate the adverse effects of 18% high starch on glucose metabolism of largemouth bass juveniles.
[0084] Table 4 Effects of Bacillus subtilis F7 on liver glycogen and sugar metabolism-related enzyme activities of juvenile largemouth bass
[0085]
[0086] (3) Effects of Bacillus subtilis F7 on liver fat content and lipid metabolism-related enzyme activities in juvenile largemouth bass
[0087] The results in Table 5 showed that compared with the C6 group, the liver fat content of the C18 group increased significantly, the activity of the fat synthesis enzyme carnitine palmitoyltransferase-1 (CPT1) increased significantly, and the activity of the fat decomposition lipoprotein lipase LPL decreased significantly (P < 0.05). Compared with the C18 group, the liver fat content of the F7 group decreased significantly, and the activity of the fat synthesis enzyme carnitine palmitoyltransferase-1 (CPT1) decreased significantly (P < 0.05). The results showed that 18% high starch led to an increase in liver fat content and liver glucose metabolism disorders in largemouth bass (promoting fat synthesis and inhibiting fat decomposition). Highland Bacillus F7 can effectively alleviate the adverse effects of 18% high starch on lipid metabolism of largemouth bass juveniles.
[0088] Table 5 Effects of Bacillus subtilis F7 on liver fat content and lipid metabolism-related enzyme activities in juvenile largemouth bass
[0089]
[0090] Items Group C6 Group C18 F7 Group Carnitine palmitoyltransferase-1 (CPT1) (ng / g) 231.48±6.33b 260.33±9.93a 225.86±3.69b Lipolytic enzymes Lipoprotein lipase LPL (U / mgprot) 56.33±2.52b 38.47±2.27a 38.28±3.48a Lipase HL (U / mgprot) 51.38±1.71b 43.71±3.05ab 36.14±3.36a
[0091] In summary, the present invention screened out a strain of Bacillus subtilis F7 from the intestine of largemouth bass, and a large number of genes involved in sugar and lipid metabolism were present in its genome, which has a biological basis for regulating host sugar and lipid metabolism. It can improve the adverse effects of high wheat starch diet on the growth performance and sugar and lipid metabolism of largemouth bass juveniles, improve the utilization rate of carbohydrates by largemouth bass, reduce feed costs, and provide a solution for the development of efficient largemouth bass feed.
[0092] Although the specific implementation modes of the present invention are described above, those skilled in the art should understand that the specific implementation modes described are only illustrative and are not intended to limit the scope of the present invention. Equivalent modifications and changes made by those skilled in the art in accordance with the spirit of the present invention should be included in the scope of protection of the claims of the present invention.
Claims
1. A strain of Bacillus subtilis, characterized in that: The Bacillus saltitudinis is Bacillus saltitudinis F7, which is deposited in the General Microbiological Center of China National Microbiological Culture Collection Committee with a deposit number of CGMCC No.28886.
2. The culture of Bacillus subtilis according to claim 1.
3. Use of the culture of the Bacillus subtilis according to claim 1 or the Bacillus subtilis according to claim 2 in the preparation of a bacterial agent or a feed additive.
4. A bacterial agent, characterized in that The bacterial agent includes the culture of the Bacillus subtilis according to claim 1 or the culture of the Bacillus subtilis according to claim 2.
5. A feed additive, characterized in that: The feed additive comprises the culture of the Bacillus subtilis according to claim 1 or the culture of the Bacillus subtilis according to claim 2.
